Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
Titel:
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
Auteur:
Lorusso, Domenica Xiang, Yang Hasegawa, Kosei Scambia, Giovanni Leiva, Manuel Ramos-Elias, Pier Acevedo, Alejandro Sukhin, Vladyslav Cloven, Noelle Pereira de Santana Gomes, Andrea J Contreras Mejía, Fernando Reiss, Ari Ayhan, Ali Lee, Jung-Yun Saevets, Valeriya Zagouri, Flora Gilbert, Lucy Sehouli, Jalid Tharavichitkul, Ekkasit Lindemann, Kristina Lazzari, Roberta Chang, Chih-Long Lampé, Rudolf Zhu, Hong Oaknin, Ana Christiaens, Melissa Polterauer, Stephan Usami, Tomoka Li, Kan Yamada, Karin Toker, Sarper Keefe, Stephen M Pignata, Sandro Duska, Linda R